Viewing Study NCT06412094



Ignite Creation Date: 2024-05-19 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06412094
Status: COMPLETED
Last Update Posted: 2024-05-14
First Post: 2024-05-05

Brief Title: Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis
Sponsor: Avanta Trading Ltd
Organization: Avanta Trading Ltd

Study Overview

Official Title: A Comparative Controlled Study of the Effectiveness of Using a Mobile Application in Managing Pediatric Atopic Dermatitis
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A randomized controlled study in children with AD divided into three groups a control group without access to the app an experimental observational group with the app and an experimental interventional group with potential investigator supervision Outcome measures included the SCORAD and the POEM scores
Detailed Description: Three study groups a control group that did not use the mobile health Atopic App an experimental observational group provided with the mobile app without supervision by the investigators and experimental interventional group provided with the mobile app with potential supervision by the investigators Upon study enrollment participants receive recommended treatment plans and instructions for contacting the doctor via messenger for any questions during treatment Virtual oversight disclosed to participant of the intervention arm including registration status and regularity of use of the app

Outcome endpoints are objective severity assessment using the SCORAD scale and subjective assessment of effectiveness using the POEM scale

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None